Top Clinical Trials companies in South Korea by Receivables
South Korea
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 749.42 M
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
| 2 |
USD 94.18 M
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
| 3 |
USD 88.97 M
|
Dec. 31, 2023 | USD 70.28 | -5.55% |
|
South Korea |
|
| 4 |
USD 20.36 M
|
Dec. 31, 2023 | USD 11.00 | -3.03% |
|
South Korea |
|
| 5 |
USD 16.41 M
|
Dec. 31, 2023 | USD 1.01 | -3.22% |
|
South Korea |
|
| 6 |
USD 10.99 M
|
Dec. 31, 2023 | USD 240.05 | -5.25% |
|
South Korea |
|
| 7 |
USD 8.24 M
|
Dec. 31, 2023 | USD 3.04 | -3.81% |
|
South Korea |
|
| 8 |
USD 5.09 M
|
Dec. 31, 2023 | USD 1.42 | -2.25% |
|
South Korea |
|
| 9 |
USD 2.73 M
|
Dec. 31, 2023 | USD 10.77 | -3.15% |
|
South Korea |
|
| 10 |
USD 2.53 M
|
Dec. 31, 2023 | USD 1.61 | -1.19% |
|
South Korea |
|
| 11 |
USD 1.75 M
|
Dec. 31, 2023 | USD 11.83 | -21.52% |
|
South Korea |
|
| 12 |
USD 1.04 M
|
Dec. 31, 2023 | USD 17.88 | -1.83% |
|
South Korea |
|
| 13 |
USD 771.90 K
|
Dec. 31, 2023 | USD 1.23 | -3.88% |
|
South Korea |
|
| 14 |
USD 318.56 K
|
Dec. 31, 2023 | USD 64.97 | -2.50% |
|
South Korea |
|
| 15 |
USD 0.29
|
Dec. 31, 2023 | USD 2.33 | -4.21% |
|
South Korea |
|
| 16 |
USD 0.27
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
| 17 |
USD 0.00
|
Dec. 31, 2023 | USD 25.27 | 1.91% |
|
South Korea |
Frequently Asked Questions
-
Which Clinical Trials company in South Korea has the highest Receivables ?
The Clinical Trials company in South Korea with the highest Receivables is Celltrion, Inc. (KSE: 068270.KS) at USD 749.42 M.
-
Which Clinical Trials company in South Korea has the lowest Receivables ?
The Clinical Trials company in South Korea with the lowest Receivables is ABL Bio Inc. (KOSDAQ: 298380.KQ) at USD 0.00.
-
What are the top 10 Clinical Trials companies in South Korea by Receivables ?
The top 10 Clinical Trials companies in South Korea by Receivables are Celltrion, Inc., ST Pharm Co.,Ltd., SK Biopharmaceuticals Co., Ltd., Boditech Med Inc., Enzychem Lifesciences Corporation, ALTEOGEN Inc., Genexine, Inc., GeneOne Life Science, Inc., OliX Pharmaceuticals,Inc and CrystalGenomics, Inc..
-
What are the bottom 10 Clinical Trials companies in South Korea by Receivables ?
The bottom 10 Clinical Trials companies in South Korea by Receivables are ABL Bio Inc., Samjin Pharmaceuticals Co., Ltd., MedPacto, Inc., Peptron, Inc., Gencurix Inc., Oscotec Inc., Anterogen.Co.,Ltd., CrystalGenomics, Inc., OliX Pharmaceuticals,Inc and GeneOne Life Science, Inc..
